Skip to main content

ORIGINAL RESEARCH article

Front. Med.
Sec. Dermatology
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1445811

Dermoscopy of skin metastases in advanced cancer -systemic (visceral, hematologic) and cutaneous

Provisionally accepted
Olga Simionescu Olga Simionescu 1*Marian Petrică Marian Petrică 2,3Alina M. Avram Alina M. Avram 1Mariana Costache Mariana Costache 1Lucian G. Scurtu Lucian G. Scurtu 1Sorin I. Tudorache Sorin I. Tudorache 4Polixenia G. Iorga Polixenia G. Iorga 1Mariana Grigore Mariana Grigore 1
  • 1 Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • 2 Faculty of Mathematics and Computer Science, University of Bucharest, Bucharest, Romania
  • 3 Gheorghe Mihoc - Caius Iacob Institute of Mathematical Statistics and Applied Mathematics of the Romanian Academy, Bucharest, Romania, Bucharest, Romania
  • 4 Titu Maiorescu University, Bucharest, Romania

The final, formatted version of the article will be published soon.

    Skin metastases arise in 10% of cancer patients, but standardized dermoscopy diagnostic criteria for skin metastases remain poor. This study's objective was to analyze the dermoscopy features of skin metastases from advanced systemic and cutaneous cancers. A retrospective study on 715 dermoscopy images of skin metastases from 33 patients with various primary cancers (breast, ovary, melanoma, non-melanoma skin cancer, chronic leukemia) attending two academic centers between 2013 and 2023 was performed. Four independent observers blindly analyzed patterns, colors, vessels, and elementary lesions for each metastasis (30 parameters in total). The structureless white pattern was the most prominent indicator of cutaneous metastasis (81.26%, p<0.001). Regardless of the primary tumor, colors pink, red, white, and tan were identified. Elementary lesions were infrequent, except for melanoma metastases that displayed dots (13.23%) and globules (11.11%). Breast cancer metastases presented: blue (41.48%) and red (34.32%) colors, irregular vessels (13.58%), and a bluenaevus pattern (22.22%). Melanoma metastases displayed: a blue-naevus pattern (61.38%), a blue color (85.71%), and a structureless-blue combination pattern (79.37%). Non-melanoma skin cancer metastases were characterized by vascular (42.11%) and angioma-like (31.58%) patterns, pink (57.89%) and red (57.89%) colors, irregular (57.89%), thin hairpin (47.37%), comma (47,37%) and thick hairpin (26,32%) vessels and a red, white and irregular vessels combination pattern (52,63%). A pink structureless combination pattern was frequent (61.05%) in chronic leukemia metastases. Ovarian cancer metastases displayed a white and tan structureless combination pattern (100%) and frequently had dotted vessels (42.85%). Papules and nodules with a white structureless pattern suggest skin metastases, regardless of the primary tumor. A blue structureless lesion is indicative of melanoma metastasis and a vascular pattern with irregular vessels indicates a non-melanoma skin cancer metastasis. Dermoscopy stands as a reliable non-invasive diagnostic method for suspected cutaneous metastases in patients with a known cancer history.

    Keywords: Cutaneous metastases, Skin metastases, Skin Cancer, Dermoscopy, diagnosis, metastases

    Received: 08 Jun 2024; Accepted: 15 Jul 2024.

    Copyright: © 2024 Simionescu, Petrică, Avram, Costache, Scurtu, Tudorache, Iorga and Grigore. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Olga Simionescu, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.